MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.isci.2026.117697

Медицинская библиотека · iScience · 2026

Inhibitory receptor profiles for joint prediction of benefit and toxicity in immune checkpoint blockade.

Wang Xiaodong, Xiong Di, Duan Bingchen, Ding Gouping, Huang Yiping, Wang Qianqian

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Immune checkpoint blockade has transformed cancer therapy, but durable benefit is limited to a subset of patients and can be accompanied by immune-related adverse events. This Review evaluates inhibitory receptor profiles as candidate biomarkers for predicting both antitumor benefit and immune toxicity. We examine how receptor abundance, co-expression, cellular lineage, clonality, spatial context, and treatment-induced dynamics shape interpretation across tissue imaging, cytometry, bulk transcriptomics, single-cell multi-omics, and spatial profiling, with particular attention to organ-specific toxicity and time-dependent analytical bias. Current evidence supports context-dependent associations, especially for multi-receptor T-cell states and early on-treatment changes, but not universal thresholds or stand-alone clinical use. Because benefit and toxicity share pathways yet arise from partly distinct biological determinants, they should remain separate model outputs. We propose a staged path from mechanistic discovery to a locked minimal assay, external validation, and prospective evaluation of clinical utility.

Для цитирования: Wang Xiaodong, Xiong Di, Duan Bingchen, Ding Gouping, Huang Yiping, Wang Qianqian. Inhibitory receptor profiles for joint prediction of benefit and toxicity in immune checkpoint blockade.. iScience. 2026. DOI: 10.1016/j.isci.2026.117697.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.